Identification of specific gene copy number changes in asbestos-related lung cancer

Cancer Research

Volumn 66, Issue 11, 2006, Pages 5737-5743

  Nymark, Penny ^a,b   Wikman, Harriet ^b,d   Ruosaari, Salla ^c   Hollmén, Jaakko ^c   Vanhala, Esa ^b   Karjalainen, Antti ^b   Anttila, Sisko ^a,b   Knuutila, Sakari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c AALTO UNIVERSITY   (Finland)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; CHROMOSOME 11P; CHROMOSOME 14Q; CHROMOSOME 19P; CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE NUMBER; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG TUMOR; MALE; PRIORITY JOURNAL; TUMOR GROWTH;

AGED; ASBESTOS; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; GENE DOSAGE; HUMANS; KARYOTYPING; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 33745275825     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0199     Document Type: Article

References (36)

1. Peto R. Smoking and death: the past 40 years and the next 40. BMJ 1994;309:937-9.
2. Karjalainen A, Anttila S. Asbestos exposure and the risk of lung cancer in urban population. In: Cheremisinoff PN, editor. Health and toxicology. Advances in environmental control technology series. Houston: Gulf Publishing Company; 1997. p. 127-36.
3. Vainio H, Boffetta P. Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health 1994;20:235-42.
4. Balsara B, Pei J, Testa J. Comparative genomic hybridization analysis. Methods Mol Med 2002;68:445-57.
5. Shaffer LG, Bejjani BA. A cytogeneticist's perspective on genomic microarrays. Hum Reprod Update 2004;10:221-6.
6. Marczynski B, Czuppon A, Marek W, Reichel G, Baur X. Increased incidence of DNA double-strand breaks and anti-ds DNA antibodies in blood of workers occupationally exposed to asbestos. Hum Exp Toxicol 1994;13:3-9.
7. Fatma N, Jain A, Rahman Q. Frequency of sister chromatid exchange and chromosomal aberrations in asbestos cement workers. Br J Ind Med 1991;48:103-5.
8. Mossman B, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998;157:1666-80.
9. Nelson H, Kelsey K. The molecular epidemiology of asbestos and tobacco in lung cancer. Oncogene 2002;21;7284-8.
10. Karjalainen A, Anttila S, Heikkila L, Karhunen P, Vainio H. Asbestos exposure among Finnish lung cancer patients: occupational history and fiber concentration in lung tissue. Am J Ind Med 1993;23:461-71.
11. Karjalainen A, Anttila S, Vanhala E, Vainio H. Asbestos exposure and the risk of lung cancer in a general urban population. Scand J Work Environ Health 1994;20:243-50.
12. ConsensusReport. Asbestos, asbestosis, and cancer: the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 1997;23:311-6.
13. Björkqvist AM, Tammilehto L, Nordling S, et al. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma, and large-cell anaplastic carcinoma of the lung. Br J Cancer 1998;77:260-9.
14. Wikman H, Nymark P, Väyrynen A, et al. CDK4 is a probable target gene in a novel amplicon on 12q13.3-q14.1 in lung cancer. Genes Chromosomes Cancer 2005;42:193-9.
15. Ruosaari S, Hollmén J. Image analysis for detecting faulty spots from microarray images. Lecture Notes in Computer Science 2002;2534:259-66.
16. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi O-P. Genome screening by comparative genomic hybridization. Trends Genet 1997;13:405-9.
17. el-Rifai W, Larramendy M, Bjorkqvist A, Hemmer S, Knuutila S. Optimization of comparative genomic hybridization using fiuorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest 1997;77:699-700.
18. Larramendy M, El-Rifai W, Knuutila S. Comparison of fluorescein isothiocyanate- and Texas red-conjugated nucleotides for direct labeling in comparative genomic hybridization. Cytometry 1998;31:174-9.
19. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 2000;60:4894-906.
20. Suzuki K, Ogura T, Yokose T, et al. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. Int J Cancer 1998;79:384-9.
21. Marsit CJ, Hasegawa M, Hirao T, et al. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer. Cancer Res 2004;64:8702-7.
22. Dopp E, Schiffmann D. Analysis of chromosomal alterations induced by asbestos and ceramic fibers, Toxicol Lett 1998;96-97:155-62.
23. Lohani M, Dopp E, Becker H-H, Seth K, Schiffmann D, Rahman Q. Smoking enhances asbestos-induced genotoxicity, relative involvement of chromosome 1: a study using multicolor FISH with tandem labeling. Toxicol Lett 2002;136:55-63.
24. De Rienzo A, Testa J. Recent advances in the molecular analysis of human malignant mesothelioma. Clin Ter 2000;151:433-8.
25. Shukla A, Flanders T, Lounsbury KM, Mossman BT. The γ- glutamylcysteine synthetase and glutathione regulate asbestos-induced expression of activator protein-1 family members and activity. Cancer Res 2004;64:7780-6.
26. Dano L, Guilly MN, Muleris M, et al. CGH analysis of radon-induced rat lung tumors indicates similarities with human lung cancers. Genes Chromosomes Cancer 2000;29:1-8.
27. 60Co γ-irradiation. Int J Radiat Biol 2002;78:625-33.
28. Leach JK, Van Tuyle G, Lin P-S, Schmidt-Ullrich R, Mikkelsen RB. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res 2001;61:3894-901.
29. Glover T. Instability at chromosomal fragile sites. Recent Results Cancer Res 1998;154:185-99.
30. Finnis M, Dayan S, Hobson L, et al. Common chromosomal fragile site FRA16D mutation in cancer cells. Hum Mol Genet 2005;14:1341-9.
31. Zainabadi K, Benyamini P, Chakrabarti R, et al. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13. Genomics 2005;85:704-14.
32. Sims-Mourtada JC, Bruce S, Mckeller MR, et al. The human AKNA gene expresses multiple transcripts and protein isoforms as a result of alternative promoter usage, splicing, and polyadenylation. DNA Cell Biol 2005;24:325-38.
33. Gu Y, Shen Y, Gibbs RA, Nelson DL. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet 1996;13:109-13.
34. Callahan G, Denison S, Phillips L, Shridhar V, Smith D. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 2003;22:590-601.
35. Moriarty HT, Webster LR. Fragile sites and bladder cancer. Cancer Genet Cytogenet 2003;140:89-98.
36. Ugnat A, Luo W, Semenciw R, Mao Y. Canadian Cancer Registries Epidemiology Research Group. Occupational exposure to chemical and petrochemical industries and bladder cancer risk in four western Canadian provinces. Chronic Dis Can 2004;25:7-15.